Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.98 EUR | 0.00% | +3.91% | +70.51% |
04-05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
03-28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Apontis Pharma AG
Upcoming events on Apontis Pharma AG
Past events on Apontis Pharma AG
09/04/2024 | Roadshow - Montega |
03/04/2024 | Investor Meeting |
28/03/2024 10:30 | Q4 2023 Earnings Call |
28/03/2024 06:30 | Q4 2023 Earnings Release |
09/11/2023 09:00 | Q3 2023 Earnings Call |
09/11/2023 06:30 | Q3 2023 Earnings Release |
03/09/2023 | German Fall Conference |
22/08/2023 | Hamburg Investor Day |
10/08/2023 08:00 | Q2 2023 Earnings Call |
10/08/2023 06:30 | Q2 2023 Earnings Release |
09/07/2023 | Extraordinary Shareholders Meeting |
14/05/2023 | Equity Forum Spring Conference |
12/05/2023 09:00 | Annual General Meeting |
09/05/2023 08:00 | Q1 2023 Earnings Call |
09/05/2023 06:30 | Q1 2023 Earnings Release |
03/04/2023 | Investor Meeting |
09/03/2023 08:00 | Q4 2022 Earnings Call |
09/03/2023 05:30 | Q4 2022 Earnings Release |
13/02/2023 | Roadshow - Montega |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 39,2 | 51,2 51,2 -0.03% | 55,7 55,6 0.17% | 37,0 35,9 3.06% | 51,1 |
EBITDA Million EUR | Released Forecast Spread | 0,00 | 4,86 5,90 -17.59% | 5,57 5,63 -1.14% | -13,3 -13,8 3.54% | 3,43 |
EBIT Million EUR | Released Forecast Spread | 0,00 | 3,12 2,45 27.18% | 3,88 3,87 0.24% | -15,2 -15,8 4.03% | 1,43 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,25 1,75 -85.81% | 3,83 3,73 2.53% | -14,8 -16,0 7.02% | 1,43 |
Net income Million EUR | Released Forecast Spread | -1,18 | -0,75 1,35 -155.2% | 2,69 2,77 -2.82% | -11,3 -14,7 23.28% | 1,03 |
EPS EUR | Released Forecast Spread | 0,00 | -0,09 0,17 -153.33% | 0,32 0,32 -2.17% | -1,33 -1,74 23.57% | 0,12 |
Announcement Date | 29/04/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 S1 | 2022 S1 | 2022 Q3 | 2024 Q1 |
---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 24,0 | 10,5 | ||
EBITDA Million EUR | Released Forecast Spread | 1,40 | -0,10 | ||
EBIT Million EUR | Released Forecast Spread | 1,20 | -0,50 | ||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2,39 | |||
Net income Million EUR | Released Forecast Spread | -2,20 | 2,35 | ||
Announcement Date | 11/08/21 | 11/08/22 | - | - |
Past sector events for Apontis Pharma AG
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APPH Stock
- APPH Stock
- Calendar Apontis Pharma AG